Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-{beta}-lactamase gene from Saudi Arabia.
Guerin
François
F
Henegar
Corneliu
C
Spiridon
Gabriella
G
Launay
Odile
O
Salmon-Ceron
Dominique
D
Poyart
Claire
C
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001398:Aztreonam / Q000627:therapeutic use; D003453:Cryptococcosis / Q000382:microbiology / Q000601:surgery; D003455:Cryptococcus neoformans / Q000472:pathogenicity; D005578:Fosfomycin / Q000627:therapeutic use; D006679:HIV Seropositivity; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000235:genetics* / Q000472:pathogenicity; D012529:Saudi Arabia; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000187:drug effects / Q000235:genetics*
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; C425108:beta-lactamase bla(vim-2); D001618:beta-Lactamases; D001398:Aztreonam